We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II trial of ^1^3^1I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomasAuthorsPress; W., O.; Eary; F., J.; Appelbaum; R., F.; Martin; J., P.PublicationThe Lancet, 1995, Vol 346, Issue 8971, p336ISSN0140-6736Publication typearticleDOI10.1016/S0140-6736(95)92225-3